Literature DB >> 20677009

Detection of nerve fiber atrophy in apparently effectively treated papilledema in idiopathic intracranial hypertension.

Robert Laemmer1, Josef G Heckmann, Christian Y Mardin, Stefan Schwab, Alexandra B Laemmer.   

Abstract

BACKGROUND: Since papilledema in idiopathic intracranial hypertension is a passive event not primarily affecting the visual tract, resolution with restitution ad integrum is expected if intracranial pressure is rebalanced. Retinal nerve fiber swelling due to papilledema in the acute phase and possible axon loss after long-lasting elevated intracranial pressure was investigated in a controlled cross-sectional study by scanning laser polarimetry.
METHODS: A cohort of 23 patients with idiopathic intracranial hypertension according to the modified Dandy diagnostic criteria, and 23 controls matched for age and gender were investigated. All patients received neurological and ophthalmologic examination including scanning laser polarimetry (GDx VCC). Patients were divided into groups depending on the presence of a papilledema (group 1) or the regression of the papilledema after initiation of therapy (group 2). Therapy was based on recommendations of the German Society of Neurology.
RESULTS: Scanning laser polarimetry showed an increase of nerve fiber thickness in group 1, and a decrease of the nerve fiber thickness in group 2 compared to controls. Ten of 13 patients showed signs of a regional axon loss in the deviation map of the GDx report, and six had a Nerve Fiber Index above 30. All patients with regressive papilledema and coincidence of visual field damage and pale optic disc appearance had a pathologic result in the GDx examination, but only four of ten patients with a pathologic GDx examination showed coincidence of pale optic disc appearance and visual field damage as sign of underlying optic disc atrophy.
CONCLUSION: In patients with apparently effective treatment of clinical symptoms and a regression of papilledema in idiopathic intracranial hypertension, a retinal axon loss was detected by scanning laser polarimetry. Axon loss was even present in patients without clinical evidence of optic nerve atrophy.

Entities:  

Mesh:

Year:  2010        PMID: 20677009     DOI: 10.1007/s00417-010-1465-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  37 in total

1.  Pseudotumor cerebri in two adolescents with acquired aplastic anemia.

Authors:  Michael R Jeng; Martha Rieman; Manoo Bhakta; Kathleen Helton; Winfred C Wang
Journal:  J Pediatr Hematol Oncol       Date:  2002-12       Impact factor: 1.289

2.  BENIGN INTRACRANIAL HYPERTENSION. III. PREGNANCY.

Authors:  M GREER
Journal:  Neurology       Date:  1963-08       Impact factor: 9.910

3.  Change of organization in the receptive fields of the cat's retina during dark adaptation.

Authors:  H B BARLOW; R FITZHUGH; S W KUFFLER
Journal:  J Physiol       Date:  1957-08-06       Impact factor: 5.182

Review 4.  Idiopathic intracranial hypertension.

Authors:  Deborah I Friedman; Daniel M Jacobson
Journal:  J Neuroophthalmol       Date:  2004-06       Impact factor: 3.042

5.  Laser scanning tomography of the optic nerve vs CSF opening pressure in idiopathic intracranial hypertension.

Authors:  J G Heckmann; M Weber; A G Jünemann; B Neundörfer; C Y Mardin
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

6.  Longitudinal changes in retinal nerve fiber layer thickness after acute primary angle closure measured with optical coherence tomography.

Authors:  Jen-Chia Tsai; Pei-Wen Lin; Mei-Ching Teng; Ing-Chou Lai
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

7.  Assessment of CSF dynamics and venous flow in the superior sagittal sinus by MRI in idiopathic intracranial hypertension: a preliminary study.

Authors:  P Gideon; P S Sørensen; C Thomsen; F Ståhlberg; F Gjerris; O Henriksen
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

8.  Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease.

Authors:  M Newton; B T Cooper
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

9.  Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.

Authors:  V Pueyo; J Martin; J Fernandez; C Almarcegui; J Ara; C Egea; L Pablo; F Honrubia
Journal:  Mult Scler       Date:  2008-04-18       Impact factor: 6.312

10.  Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri).

Authors:  F Gjerris; P Soelberg Sørensen; S Vorstrup; O B Paulson
Journal:  Ann Neurol       Date:  1985-02       Impact factor: 10.422

View more
  3 in total

1.  Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Authors:  Hanne M Yri; Marianne Wegener; Birgit Sander; Rigmor Jensen
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

2.  Macular thickness measurements with frequency domain-OCT for quantification of axonal loss in chronic papilledema from pseudotumor cerebri syndrome.

Authors:  M L R Monteiro; C L Afonso
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

3.  Incidental idiopathic intracranial hypertension.

Authors:  Lidia Remolí Sargues; María Isabel Soler Sanchis; Clara Monferrer Adsuara; Carolina García Villanueva; Belén López Salvador; Enrique Cervera Taulet
Journal:  Rom J Ophthalmol       Date:  2021 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.